XML 36 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

Note 15 - Segment Data

12 Months Ended

Mar. 31, 2018

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

1

5

.

Segment Data

We have

four

operating segments: Sterilization and Disinfection Control (formerly named Biological Indicators), Instruments, Cold Chain Monitoring and Cold Chain Packaging. The following tables set forth our segment information (in thousands):

		Year Ended March 31, 201 8
		Sterilization and Disinfection Control				Instruments				Cold Chain Monitoring				Cold Chain Packaging				Total
Revenues		$	43,260			$	34,104			$	12,978			$	5,837			$	96,179
Gross profit		$	29,333			$	20,395			$	3,854			$	1,037				54,619
Reconciling items (1)																			(54,318	)
Earnings before income taxes																		$	301

		Year Ended March 31, 201 7
		Sterilization and Disinfection Control				Instruments				Cold Chain Monitoring				Cold Chain Packaging				Total
Revenues		$	38,635			$	34,405			$	12,584			$	8,041			$	93,665
Gross profit		$	25,674			$	21,037			$	4,557			$	1,971				53,239
Reconciling items (1)																			(38,943	)
Earnings before income taxes																		$	14,296

		Year Ended March 31, 201 6
		Sterilization and Disinfection Control				Instruments				Cold Chain Monitoring				Cold Chain Packaging				Total
Revenues		$	33,649			$	35,692			$	11,566			$	3,752			$	84,659
Gross profit		$	22,205			$	23,223			$	4,201			$	1,784				51,413
Reconciling items (1)																			(35,858	)
Earnings before income taxes																		$	15,555

(

1

)

Reconciling items include selling, general and administrative, research and development, impairment of goodwill and other expenses.

Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):

		Year E nded March 31,
		201 8				201 7				201 6
Revenues from unaffiliated customers
United States		$	56,998			$	52,989			$	53,094
Foreign			39,181				40,676				31,565
		$	96,179			$	93,665			$	84,659

No

foreign country exceeds

ten

percent of total revenues.

		March 31,
		201 8				201 7
Total assets
Sterilization and Disinfection Control		$	83,452			$	67,233
Instruments			33,479				40,805
Cold Chain Monitoring			30,796				35,789
Cold Chain Packaging			7,091				20,313
Corporate and administrative			9,283				7,593
		$	164,101			$	171,733

All long-lived assets are located in the United States except for

$6,765,000,

$7,079,000

and

$17,068,000

which are associated with our French, Canadian and German subsidiaries, respectively.

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration